Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer, 2024

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-12-20: Form 6-K; Period of report 2024-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0225514-6k_altamira.htm.
  • 2024-10-04: Form 6-K; Period of report 2024-10-04; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0216654-6k_altamira.htm.
  • 2024-09-24: Form 6-K; Period of report 2024-06-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0213577-6k_altamira.htm.
  • 2024-09-19: Form 6-K; Period of report 2024-09-19; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0215114-6k_altamira.htm.
FiledFormPeriod of reportDescriptionDocument
2024-12-206-K2024-12-20REPORT OF FOREIGN PRIVATE ISSUERea0225514-6k_altamira.htm
2024-10-046-K2024-10-04REPORT OF FOREIGN PRIVATE ISSUERea0216654-6k_altamira.htm
2024-09-246-K2024-06-30REPORT OF FOREIGN PRIVATE ISSUERea0213577-6k_altamira.htm
2024-09-196-K2024-09-19REPORT OF FOREIGN PRIVATE ISSUERea0215114-6k_altamira.htm
2024-05-166-K2024-05-16REPORT OF FOREIGN PRIVATE ISSUERea0206215-6k_altamira.htm
2024-04-166-K2024-04-16REPORT OF FOREIGN PRIVATE ISSUERea0203892-6k_altamira.htm
2024-04-106-K2024-04-10REPORT OF FOREIGN PRIVATE ISSUERea0203620-6k_altamira.htm
2024-01-196-K2024-01-19REPORT OF FOREIGN PRIVATE ISSUERea191800-6k_altamira.htm
2024-01-196-K2024-01-19REPORT OF FOREIGN PRIVATE ISSUERea191765-6k_altamira.htm